Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nebraska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nebraska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nebraska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Inaganti Shah — Billing Profile & Reimbursement Data

NPI 1295829042 · Omaha, NE · Hematology & Oncology Physician

Customize your policy alerts

Sign up for Inaganti Shah — Billing Profile & Reimbursement Data policy alerts

Get alerted when relevant policies change without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Inaganti Shah is a hematology & oncology physician provider located in Omaha, Nebraska. This profile covers 61 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

Inaganti Shah — Billing Profile & Reimbursement Data

NPI 1295829042 · Omaha, NE · Hematology & Oncology Physician

Customize your policy alerts

Sign up for Inaganti Shah — Billing Profile & Reimbursement Data policy alerts

Get alerted when relevant policies change without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Provider details (source: NPPES NPI Registry)

Field	Value
Entity Type	Individual
Organization	Inaganti Shah
Address	6901 N 72nd St
City	Omaha
State	NE
ZIP	68122
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	October 3, 2006

Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

This provider is a hematology & oncology physician with a Medicare lifetime revenue profile of $2M and no Medicaid billing on file, making their practice effectively single-payer (Medicare) in the available dataset. The NPI was enumerated on 2006-10-03 (~20 years ago), indicating long tenure in Medicare billing which supports established outpatient oncology services rather than a newly formed practice. Revenue concentration is high: the precomputed top 3 Medicare codes account for 60.1% of the provider's total Medicare revenue, signaling dependence on a small set of high-cost oncology drug administrations. The top single code is J9271 (pembrolizumab) with $567.6K revenue (29.2% of total Medicare revenue) and a national rank at the 54th percentile; this places the provider as a typical, non-dominant participant for this high-revenue immunotherapy. J9144 (daratumumab) and J0897 (denosumab) are the other major drivers ($376.2K and $226.8K respectively, jointly with J9271 forming the 60.1% share), with J9144 ranking at the 64th percentile (typical volume) and J0897 at the 92th percentile (typical volume but relatively high percentile nationally), indicating notable usage of monoclonal antibody therapies and supportive bone-modifying agents. Several E/M visit codes (99214 and 99215) are reported at notably above typical national volume (96th and 97th percentiles respectively) and together with chemotherapy administration codes (96413, 96365, 96367) suggest the practice combines infusion-based oncology care with substantial office follow-up and complex chronic management. The provider shows unusually high national percentile usage for a few supportive or low-reimbursement items (for example, 96372 at the 98th percentile and J0881 at the 93th percentile), which indicates higher-than-typical frequency of therapeutic injections and non-ESRD epoetin-class administrations relative to peers. Overall, the code mix—heavy on J-codes for pembrolizumab, daratumumab, denosumab, and other biologics—aligns with a specialty infusion center or oncology clinic focused on modern cancer immunotherapies and supportive biologic agents rather than primarily office-based procedural specialties.

Medicare revenue breakdown by CPT/HCPCS procedure code.

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	13,200	$40	$567.6K
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	9,900	$40	$376.2K
J0897	Injection, denosumab, 1 mg	12,600	$20	$226.8K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	3,680	$40	$136.2K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	46,440	$1	$92.9K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	4,020	$20	$92.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	800	$90	$70K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	1,580	$40	$56.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	470	$90	$44.5K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	460	$90	$42.9K

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 61 CPT/HCPCS codes.

Full comparison — all codes billed, vs. state median

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	17	30	14,400	$40	$671.6K
J9144	7	10	10,440	$40	$434.6K
Q5107	3	10	5,670	$20	$138.2K
J1459	1	10	3,160	$40	$117.4K
Q5115	3	10	1,920	$30	$73.4K
J0897	7	200	2,040	$20	$62.7K
J0881	2	10	17,260	$1	$54.5K
J1454	2	10	110	$350	$41.5K
J2506	10	20	460	$90	$40.5K
Q5108	6	10	410	$90	$35.7K

Other providers that share a Tax Identification Number (TIN) with Inaganti Shah, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Oneworld Community Health Centers, Inc.	NE	Federally Qualified Health Center (FQHC)	$0	$45.1M
Alegent Creighton Clinic	NE	Family Medicine Physician	$0	$43.2M
Alegent Creighton Clinic	IA	Family Medicine Physician	$0	$9.6M
Samer Renno	NE	Hematology & Oncology Physician	$3.2M	$0
Rabih Fahed	NE	Hematology & Oncology Physician	$2M	$0
Timothy Dorius	NE	Internal Medicine Physician	$1M	$0
Logan Helge	NE	Family Nurse Practitioner	$996.6K	$0
Nagendra Natarajan	NE	Hematology & Oncology Physician	$934.8K	$0
Hematology & Oncology Consultants, PC	NE	Hematology & Oncology Physician	$0	$578.6K
James Shehan	NE	Dermatology Physician	$401.5K	$0

Other providers in the same ZIP code as Inaganti Shah, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Alegent Health Immanuel Medical Center	NE	General Acute Care Hospital	$0	$23.7M
Alegent Creighton Health	NE	Internal Medicine Physician	$0	$17.5M
Emergency Clinicians Associates, LLC	NE	Emergency Medical Services (Emergency Medicine) Physician	$0	$6.5M
Alegent Health Immanuel Medical Center	NE	Psychiatric Hospital Unit	$0	$847.8K
Matthew Brumm	NE	Ophthalmology Physician	$593.3K	$0
Abraham Mathews	NE	Hematology & Oncology Physician	$369.1K	$0
Bruce H Brumm Md PC	NE	Ophthalmology Physician	$0	$362.6K
Bruce Baron	NE	Diagnostic Radiology Physician	$282.4K	$0
Charles Schlaepfer	NE	Diagnostic Radiology Physician	$225.4K	$0
Family Ear Nose & Throat Clinic PC	NE	Otolaryngology Physician	$0	$190.5K

Inaganti Shah — Billing Profile & Reimbursement Data

Sign up for Inaganti Shah — Billing Profile & Reimbursement Data policy alerts

Inaganti Shah — Billing Profile & Reimbursement Data

Sign up for Inaganti Shah — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References